CD274 and cancer: Cytotoxic activity in the four cancer cell lines tested was not observed for 1 and 2, as in the case of gunungamide A and cyclocinamide B. In addition, an anticancer immune response was also evaluated, and neither compound was able to impair PD1–PDL1 interaction.